SVB Leerink Maintains Underperform on Moderna, Raises Price Target to $86

SVB Leerink analyst Mani Foroohar maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $85 to $86.

SVB Leerink analyst Mani Foroohar maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $85 to $86.

Total
0
Shares
Related Posts